Analysts: Qihoo’s Monetization Trends Are Promising and 3 Other Research Notes to Explore

Qihoo 360 (NYSE:QIHU): Citigroup increased its 2013-2015 earnings estimates for Qihoo 360 by 20 percent to 30 percent after the company reported stronger-than-expected second-quarter results. The firm thinks the company’s search traffic and monetization trends are promising and raised its price target on the shares to $87 from $65 while keeping a Buy rating on the stock.


Amgen (NASDAQ:AMGN): After Amgen agreed to buy Onyx Pharmaceuticals (NASDAQ:ONXX) for $125 per share, Citigroup believes the financing costs for the deal are “very cheap.” The firm thinks the deal will provide Amgen with much-need revenue growth, and it expects the transaction to be accretive in 2015. Citi keeps a Buy rating on Amgen.


Monsanto (NYSE:MON): UBS has upgraded Monsanto based on the year-to-date selloff in shares and expectations for stabilizing corn prices. Its price target on the stock remains at $110.


Uni-Pixel (NASDAQ:UNXL): Cowen has spoken with Kodak (NYSE:EKDKQ) and believes that the Rochester facility is on track to produce 1 million units per month by year’s end. Uni-Pixel and Kodak are both investing $12.5 million for equipment and facilities improvements, and full production capability is expected by November 15. Shares of Uni-Pixel are rated at Outperform with a $46 price target.


Don’t Miss: Are Google Robo-Taxis a Real Possibility?